シン シンバイオ製薬株式会社 Stock: price and insider trades · Japan · EDINET (Japan FSA)Track the シンバイオ製薬株式会社 stock price and the full insider trade history of the company, a listed equity based in Japan. Shares are quoted on the JP market, under the oversight of EDINET (Japan FSA). Market capitalisation: €5bn. The latest transaction was filed on 18 September 2026 (Holding update). Among the most active insiders: Evo Fund. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ Sigma AI Analysis Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 18 September 2026
All Executives48 Thresholds0 Prospectus0 Other0
Declarations 48 total
● Large shareholder · Executives · 11 Sept 2026
● Large shareholder · Executives · 2 Sept 2026
0.055% mcap 3.5% of flow Share EDINET:S100Z0ZR ● Large shareholder · Executives · 31 Aug 2026
● Large shareholder · Executives · 18 Aug 2026
5.49% mcap 50.2% of flow Share EDINET:S100YY0M ● Officer · Executives · 29 Jul 2026
● Large shareholder · Executives · 18 Aug 2026
0.022% mcap 1.4% of flow Share EDINET:S100YYH2 ● Large shareholder · Executives · 29 Jul 2026
5.41% mcap 100.0% of flow Share EDINET:S100YUCP ● Large shareholder · Executives · 29 Jul 2026
0.022% mcap 1.4% of flow Share EDINET:S100YTTB ● Large shareholder · Executives · 1 Jul 2026
0.027% mcap 1.8% of flow Share EDINET:S100YPA2 ● Large shareholder · Executives · 29 Jun 2026
0.027% mcap 1.8% of flow Share EDINET:S100YOV6 ● Large shareholder · Executives · 27 Apr 2026
2.0% of flow Share EDINET:S100Y25R ● Large shareholder · Executives · 15 Apr 2026
2.1% of flow Share EDINET:S100Y03B ● Large shareholder · Executives · 9 Apr 2026
2.2% of flow Share EDINET:S100XYQP ● Large shareholder · Executives · 1 Apr 2026
2.3% of flow Share EDINET:S100XXJC ● Large shareholder · Executives · 27 Feb 2026
7.5% of flow Share EDINET:S100XOSF ● Officer · Executives · 24 Feb 2026
9.4% of flow Share EDINET:S100XO6F ● Large shareholder · Executives · 24 Feb 2026
9.4% of flow Share EDINET:S100XO5M ● Large shareholder · Executives · 18 Feb 2026
28.8% of flow Share EDINET:S100XN52 ● Large shareholder · Executives · 17 Feb 2026
2.9% of flow Share EDINET:S100XN1O ● Large shareholder · Executives · 10 Feb 2026
3.0% of flow Share EDINET:S100XM0M ● Large shareholder · Executives · 3 Feb 2026
3.1% of flow Share EDINET:S100XJXJ ● Large shareholder · Executives · 19 Jan 2026
3.2% of flow Share EDINET:S100XH6E ● Large shareholder · Executives · 15 Jan 2026
3.3% of flow Share EDINET:S100XGI6 ● Large shareholder · Executives · 8 Jan 2026
3.6% of flow Share EDINET:S100XFXO ● Large shareholder · Executives · 5 Jan 2026
3.6% of flow Share EDINET:S100XF5L 25 of 48 declarations
Load more (23 remaining) About シンバイオ製薬株式会社 シンバイオ製薬株式会社 is a Japanese company focused on developing innovative drugs for cancer treatment. It is listed on the XTKS market.